Phone: (707) 546-5553
Email Us
1140 Sonoma Avenue 1-A
Santa Rosa, CA 95405

HIFU FDA Approved

Cyclist is back doing what he likes best after HIFU procedure

Matthew Hoffman, 59, was having regular annual physical exams that included blood tests. In 2010 one test showed that the Prostate-­Specific Antigen (PSA) was high. Dr. Michael Lazar advised him to have a biopsy, which was negative. However, precursors for cancer were present, meaning that his situation had to be watched closely. A year later, his PSA level had risen to 7. [...]

August 8th, 2017|

First Prostate Cancer Patient Treated with Minimally Invasive HIFU on West Coast

Dr. Michael Lazar performing first HIFU surgery on the West Coast at San Francisco Surgery Center November 18, 2015. San Francisco, CA – HIFU Prostate Services, LLC, a leading provider of minimally- invasive prostate cancer treatment, using High Intensity Focused Ultrasound (HIFU), announced that physician partner and Medical Director, Michael J. Lazar, MD [...]

November 18th, 2015|

Minimally Invasive Prostate Cancer Treatment HIFU Now Available in the U.S.

After much anticipation the FDA has finally approved for market in the United States the Sonablate® for the ablation of prostate tissue. Sonablate® is the first High Intensity Therapeutic Ultrasound (HITU) device to receive FDA regulatory authorization for prostate tissue ablation. HIFU offers an effective treatment for localized prostate cancer with significantly less risk of [...]

November 12th, 2015|